Lilly Manifesto for Europe Accelerating access and innovation

Lilly invites candidates to endorse a Europe that invests in health and biomedical advances. To welcome innovation, a single conversation is needed, that joins up industrial policy for growth and considers true value of medicines. We call for policies and pragmatic solutions to accelerate access to innovative medicines, improving health outcomes and health system sustainability, and to make Europe a globally competitive hub for the biopharmaceutical industry. Read the full text, by clicking on the pdf link below.

Tags in this Article:

No categories

Related articles

Lilly Receives European Marketing Authorization for tirzepatide (Mounjaro®) in for...

Lilly Receives European Marketing Authorization for tirzepatide (Mounjaro®) in KwikPen® Presentation for Two Indications Brussels, April, 24nd 2024 – Eli Lilly and Company announced that the European Commission (EC) granted marketing authorization (MA) on 19 April 2024 for tirzepatide (Mounjaro®) solution for injection in a multi-dose KwikPen® presentation, for two indications.

Why the Obesity crisis threatens the world's financial stability

The Telegraph post on why the obesity crisis threatens the world's financial stability.

Strengthening European Competitiveness and Access

Strengthening European Competitiveness and Access